Cancer: A Problem of Developmental Biology; Scientific Evidence for Reprogramming and Differentiation Therapy

Stewart Sell, Andrea Nicolini, Paola Ferrari

  • 1Scientific Institute of Research and Care Multimedica, Milan, Italy. biava@tiscali.it.

Current Drug Targets
|September 8, 2015
PubMed

Insights

The embryonic microenvironment can suppress tumor development, suggesting cancer is a developmental biology problem. Cancer cells can differentiate into normal tissues when exposed to embryonic factors, offering new therapeutic avenues.

Area of Science:

  • Developmental Biology
  • Cancer Research
  • Cell Biology

Background:

  • The embryonic microenvironment exhibits tumor-suppressive properties.
  • Cancer is increasingly viewed as a deviation from normal development.
  • Embryonic exposure to carcinogens during organogenesis prevents tumors, but not after.

Purpose of the Study:

  • To review research on cancer cell reprogramming and differentiation.
  • To explore how embryonic or biological substances induce malignant cell differentiation.
  • To propose a novel cancer model integrating existing theories.

Main Methods:

  • Literature review of studies on embryonic microenvironment and cancer.
  • Analysis of research on teratoma, melanoma, and other tumor differentiation in embryos.
  • Integration of "maturation arrest" and "deterministic chaos" theories of cancer.

Main Results:

  • Embryonic implantation causes teratoma and melanoma cells to differentiate into normal tissues.
  • Cancer cells demonstrate potential for reversion to normal phenotype within the embryonic environment.
  • The embryonic microenvironment actively suppresses tumor formation.

Conclusions:

  • Cancer is fundamentally a developmental biology issue.
  • Loss of differentiation is a key hallmark of cancer.
  • Embryonic factors offer potential for cancer differentiation therapies.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.3K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.3K
What is Cancer?02:12

What is Cancer?

Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
15.7K